Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma Meeting Abstract


Authors: Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Portlock, C. S.; Straus, D. J.; Chen, A.; Little, R. F.; France, F.; Whang, J.; Mishra, N.; Jarjies, C.; Gerecitano, J. F.
Abstract Title: Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368020102203
PROVIDER: wos
Notes: Meeting Abstract: 2691 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
MSK Authors
  1. Carol Portlock
    178 Portlock
  2. Craig Moskowitz
    371 Moskowitz
  3. Ariela Noy
    204 Noy
  4. Maria Lia Palomba
    121 Palomba
  5. Steven M Horwitz
    351 Horwitz
  6. Andrew D Zelenetz
    547 Zelenetz
  7. Alison Moskowitz
    141 Moskowitz
  8. Paul Hamlin
    170 Hamlin
  9. Matthew J Matasar
    119 Matasar
  10. David J Straus
    205 Straus
  11. Anas Younes
    195 Younes
  12. Juho Patrick Whang
    3 Whang
  13. Fallon Olga France
    4 France
  14. Nishant   Mishra
    2 Mishra
Related MSK Work